We only have this paper's title and publication details.
Read it at the sourceAgency fines Cassava Sciences $40 million for touting flawed research on simufilam.
No takes yet. Share an insight, caveat, or question.
Charles Piller (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: